Cumulative incidence of restenosis in the endovascular treatment of extracranial carotid artery stenosis: a meta-analysis.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 01 12 2018
revised: 09 01 2019
accepted: 09 01 2019
pubmed: 2 2 2019
medline: 27 11 2019
entrez: 2 2 2019
Statut: ppublish

Résumé

To assess the cumulative incidence of restenosis and stroke after stenting for cervical carotid artery stenosis. We reviewed PubMed, ScienceDirect, and Scopus and included all studies reporting restenosis after stenting. The cumulative incidence of restenosis at 6 and 12 months was calculated. We also estimated the cumulative incidence of ipsilateral stroke within 30 days after stenting. Random effect meta-analysis and meta-regression were performed using relevant study level covariates. Sources of heterogeneity were investigated. Among 7765 records, 40 studies were selected. 15 943 patients and 16 337 carotid arteries were considered. The overall pooled cumulative incidence of restenosis >50% at 12 months was 5.7% (95% CI 3.8% to 8.6%), >70% at 12 months was 5.2% (95% CI 3.3% to 8.2%), >50% at 6 months was 3.9% (95% CI 2.2% to 6.8%), and ipsilateral stroke within 30 days after stenting was 1.6% (95% CI 1.0% to 2.5%) without association with the use of an embolic protection device. We did not identify any relevant source of heterogeneity of the cumulative incidence of restenosis >50% at 12 months. Mean age explained 80.9% (R This meta-analysis showed a low cumulative rate of restenosis at 12 months and ipsilateral stroke within 30 days after stenting. Older patients and those with hostile neck present a lower risk of in-stent restenosis. The use of an embolic protection device was not associated with a lower risk of stroke.

Identifiants

pubmed: 30705056
pii: neurintsurg-2018-014534
doi: 10.1136/neurintsurg-2018-014534
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

916-923

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Pierre Clavel (P)

Service de Radiologie, CHU Limoges, Limoges, France.

Solène Hebert (S)

Service de Neurologie, CHU Limoges, Limoges, France.

Suzana Saleme (S)

Service de Radiologie, CHU Limoges, Limoges, France.

Charbel Mounayer (C)

Service de Radiologie, CHU Limoges, Limoges, France.
CNRS, XLIM, UMR 7252, Univ. Limoges, Limoges, France.

Aymeric Rouchaud (A)

Service de Radiologie, CHU Limoges, Limoges, France.
CNRS, XLIM, UMR 7252, Univ. Limoges, Limoges, France.

Benoit Marin (B)

CHU Limoges, Centre d'Epidémiologie de Biostatistique et de Méthodologie de la Recherche, Limoges, France.
Tropical Neuroepidemiology, INSERM, UMR1094, Limoges, France.
Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Univ. Limoges, UMR_S 1094, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH